Total Payments
$5,781
2024 Payments
$135.30
Companies
17
Transactions
66
Medicare Patients
11,139
Medicare Billing
$10.3M
Payment Breakdown by Category
Gifts$3,760 (65.0%)
Food & Beverage$1,078 (18.6%)
Other$849.66 (14.7%)
Education$93.64 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $3,760 | 4 | 65.0% |
| Food and Beverage | $1,078 | 59 | 18.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $849.66 | 2 | 14.7% |
| Education | $93.64 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Carl Zeiss Meditec, Inc. | $3,741 | 3 | $0 (2019) |
| Notal Vision, Inc. | $499.66 | 1 | $0 (2021) |
| Allergan, Inc. | $440.61 | 6 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $352.34 | 18 | $0 (2024) |
| Halozyme Inc | $134.00 | 1 | $0 (2021) |
| ABBVIE INC. | $114.11 | 7 | $0 (2024) |
| EyePoint Pharmaceuticals US, Inc. | $107.27 | 4 | $0 (2023) |
| Genentech USA, Inc. | $90.57 | 6 | $0 (2023) |
| Alimera Sciences, Inc. | $83.83 | 6 | $0 (2021) |
| Apellis Pharmaceuticals, Inc. | $67.32 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $135.30 | 8 | Regeneron Healthcare Solutions, Inc. ($53.51) |
| 2023 | $190.65 | 9 | EyePoint Pharmaceuticals US, Inc. ($63.59) |
| 2021 | $701.36 | 6 | Notal Vision, Inc. ($499.66) |
| 2020 | $394.18 | 4 | Allergan, Inc. ($360.16) |
| 2019 | $2,491 | 12 | Carl Zeiss Meditec, Inc. ($2,359) |
| 2018 | $1,511 | 11 | Carl Zeiss Meditec, Inc. ($1,382) |
| 2017 | $357.93 | 16 | Regeneron Healthcare Solutions, Inc. ($173.49) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/02/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Ophthalmology | ||||||
| 05/15/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: EYE CARE | ||||||
| 04/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/22/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Ophthalmology | ||||||
| 02/17/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: EYE CARE | ||||||
| 02/06/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/09/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Immunology and Ophthalmology | ||||||
| 11/14/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/13/2023 | Hologic Sales and Service, LLC | ACESSA PROVU SYSTEM (Device), CoolSeal Generator | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Surgical | ||||||
| 10/13/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/22/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/07/2023 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/30/2023 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/12/2023 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $63.59 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 05/09/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $15.45 | General |
| Category: Ophthalmology | ||||||
| 04/28/2023 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $18.10 | General |
| Category: Ophthalmology | ||||||
| 07/30/2021 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/09/2021 | Notal Vision, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $499.66 | General |
| 06/25/2021 | EyePoint Pharmaceuticals US, Inc. | YUTIQ (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Chronic Non-infectious Posterior Segment Uveitis | ||||||
| 06/04/2021 | Halozyme Inc | HYLENEX RECOMBINANT (Drug) | Food and Beverage | In-kind items and services | $134.00 | General |
| Category: Opthalmology | ||||||
| 05/04/2021 | Bausch & Lomb, a division of Bausch Health US, LLC | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Ophthalmology | ||||||
| 03/29/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $16.65 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/23/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 04/17/2020 | Allergan, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $350.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 2,748 | 43,430 | $5.0M | $2.5M |
| 2022 | 19 | 2,919 | 17,069 | $5.2M | $2.5M |
| 2021 | 16 | 2,811 | 9,435 | $5.2M | $2.6M |
| 2020 | 15 | 2,661 | 9,707 | $5.3M | $2.7M |
Total Patients
11,139
Total Services
79,641
Medicare Billing
$10.3M
Procedure Codes
67
All Medicare Procedures & Services
67 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 107 | 35,640 | $1.8M | $1.0M | 57.5% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 136 | 1,158 | $1.5M | $794,106 | 52.8% |
| J3490 | Unclassified drugs | Office | 2023 | 40 | 106 | $307,400 | $187,963 | 61.1% |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | Office | 2023 | 40 | 1,185 | $237,000 | $142,627 | 60.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 261 | 1,228 | $613,200 | $127,705 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 594 | 731 | $146,200 | $71,067 | 48.6% |
| 92134 | Imaging of retina | Office | 2023 | 800 | 1,942 | $193,910 | $62,534 | 32.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 235 | 682 | $102,300 | $47,737 | 46.7% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 160 | 287 | $38,745 | $20,407 | 52.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 80 | 80 | $24,000 | $10,895 | 45.4% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 60 | 137 | $12,330 | $7,442 | 60.4% |
| 92250 | Photography of the retina | Office | 2023 | 115 | 118 | $14,750 | $3,847 | 26.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 45 | 46 | $9,200 | $3,439 | 37.4% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 15 | 23 | $6,900 | $929.92 | 13.5% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 12 | 13 | $1,950 | $723.06 | 37.1% |
| 92201 | Extended exam of the back part of the eye with retinal drawing | Office | 2023 | 29 | 33 | $1,650 | $687.58 | 41.7% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 19 | 21 | $1,155 | $483.40 | 41.9% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 210 | 1,926 | $2.5M | $1.4M | 55.3% |
| J3590 | Unclassified biologics | Office | 2022 | 81 | 195 | $650,430 | $344,158 | 52.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 87 | 8,700 | $435,000 | $256,039 | 58.9% |
| 67028 | Injection of drug into eye | Office | 2022 | 269 | 1,267 | $643,200 | $134,101 | 20.8% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2022 | 22 | 294 | $123,480 | $72,807 | 59.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 578 | 724 | $144,800 | $72,713 | 50.2% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 12 | 309 | $169,950 | $69,894 | 41.1% |
| 92134 | Imaging of retina | Office | 2022 | 790 | 2,061 | $205,620 | $67,976 | 33.1% |
About Dr. Thomas Margolis, MD
Dr. Thomas Margolis, MD is a Ophthalmology healthcare provider based in Northfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1730153461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Margolis, MD has received a total of $5,781 in payments from pharmaceutical and medical device companies, with $135.30 received in 2024. These payments were reported across 66 transactions from 17 companies. The most common payment nature is "Gift" ($3,760).
As a Medicare-enrolled provider, Margolis has provided services to 11,139 Medicare beneficiaries, totaling 79,641 services with total Medicare billing of $10.3M. Data is available for 4 years (2020–2023), covering 67 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist, Ophthalmology
- Location Northfield, NJ
- Active Since 02/17/2006
- Last Updated 09/12/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1730153461
Products in Payments
- VISUCAM Fundus Cameras (Device) $3,741
- EYLEA AFLIBERCEPT INJECTION (Biological) $198.17
- HYLENEX RECOMBINANT (Drug) $134.00
- OZURDEX (Drug) $114.51
- YUTIQ (Drug) $107.27
- EYLEA (Biological) $84.95
- Lucentis (Biological) $74.25
- EYLEA HD (Biological) $69.22
- Syfovre (Drug) $67.32
- Humira (Biological) $67.07
- BEOVU (Drug) $32.79
- Vabysmo (Drug) $30.28
- Iluvien (Drug) $29.13
- ACTHAR (Biological) $26.57
- None Specified (Medical Supply) $19.40
- VISUDYNE (Drug) $16.98
- ILUVIEN (Drug) $16.65
- ACESSA PROVU SYSTEM (Device) $15.69
- VYZULTA (Drug) $13.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.